The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: A host-targeting treatment strategy
Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Kwok-Yung Yuen(Hong Kong Baptist University), Zheng Zhu(University of Hong Kong), Shuofeng Yuan(University of Hong Kong - Shenzhen Hospital), Huiping Shuai(University of Hong Kong), Xi Zhang(University of Hong Kong), Hin Chu(University of Hong Kong), Cyril Chik‐Yan Yip(Queen Mary Hospital), Zijiao Zou(University of Hong Kong), Kah-Meng Tee(University of Hong Kong), Gang Lu(Hainan Medical University), Kenn Ka‐Heng Chik(University of Hong Kong), Vincent Kwok‐Man Poon(Queen Mary Hospital), Jessica Oi‐Ling Tsang(University of Hong Kong), Chris Chung‐Sing Chan(University of Hong Kong)
Cited by 46
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k